Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 17 studies | 44% ± 20% | |
| oligodendrocyte | 14 studies | 40% ± 16% | |
| endothelial cell | 14 studies | 29% ± 12% | |
| oligodendrocyte precursor cell | 12 studies | 32% ± 14% | |
| GABAergic neuron | 10 studies | 39% ± 22% | |
| glutamatergic neuron | 9 studies | 45% ± 24% | |
| adipocyte | 9 studies | 27% ± 9% | |
| type I pneumocyte | 8 studies | 32% ± 12% | |
| fibroblast | 7 studies | 26% ± 7% | |
| interneuron | 6 studies | 42% ± 23% | |
| macrophage | 6 studies | 24% ± 7% | |
| retinal ganglion cell | 6 studies | 38% ± 14% | |
| smooth muscle cell | 6 studies | 20% ± 3% | |
| neuron | 5 studies | 34% ± 15% | |
| amacrine cell | 5 studies | 25% ± 3% | |
| epithelial cell | 5 studies | 37% ± 26% | |
| retina horizontal cell | 5 studies | 27% ± 6% | |
| retinal cone cell | 5 studies | 33% ± 6% | |
| cardiac muscle cell | 5 studies | 50% ± 9% | |
| ciliated cell | 5 studies | 20% ± 5% | |
| Mueller cell | 5 studies | 26% ± 5% | |
| endothelial cell of lymphatic vessel | 5 studies | 22% ± 3% | |
| club cell | 5 studies | 28% ± 13% | |
| type II pneumocyte | 5 studies | 24% ± 6% | |
| retinal bipolar neuron | 4 studies | 22% ± 5% | |
| granule cell | 4 studies | 26% ± 7% | |
| microglial cell | 4 studies | 25% ± 7% | |
| retinal rod cell | 4 studies | 30% ± 9% | |
| GABAergic interneuron | 3 studies | 28% ± 2% | |
| glial cell | 3 studies | 22% ± 2% | |
| OFF-bipolar cell | 3 studies | 22% ± 5% | |
| ON-bipolar cell | 3 studies | 26% ± 6% | |
| rod bipolar cell | 3 studies | 26% ± 4% | |
| abnormal cell | 3 studies | 22% ± 4% | |
| ependymal cell | 3 studies | 38% ± 23% | |
| alveolar macrophage | 3 studies | 19% ± 4% | |
| monocyte | 3 studies | 20% ± 5% | |
| pericyte | 3 studies | 23% ± 8% | |
| basal cell | 3 studies | 43% ± 25% | |
| goblet cell | 3 studies | 42% ± 31% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 10030.09 | 1445 / 1445 | 100% | 39.67 | 183 / 183 |
| thymus | 100% | 12723.38 | 653 / 653 | 100% | 58.96 | 603 / 605 |
| prostate | 100% | 9634.54 | 244 / 245 | 100% | 65.32 | 502 / 502 |
| brain | 100% | 13029.55 | 2641 / 2642 | 99% | 69.46 | 701 / 705 |
| adrenal gland | 100% | 6834.89 | 258 / 258 | 99% | 47.35 | 228 / 230 |
| skin | 100% | 9895.28 | 1800 / 1809 | 99% | 35.98 | 468 / 472 |
| breast | 100% | 4976.27 | 457 / 459 | 99% | 34.57 | 1103 / 1118 |
| kidney | 100% | 6563.35 | 89 / 89 | 97% | 27.21 | 877 / 901 |
| intestine | 100% | 7839.03 | 966 / 966 | 97% | 20.19 | 510 / 527 |
| uterus | 100% | 7718.56 | 170 / 170 | 96% | 30.70 | 439 / 459 |
| bladder | 100% | 7251.05 | 21 / 21 | 96% | 24.96 | 482 / 504 |
| stomach | 100% | 6337.74 | 359 / 359 | 95% | 20.58 | 273 / 286 |
| lung | 99% | 5531.94 | 572 / 578 | 95% | 21.39 | 1103 / 1155 |
| pancreas | 88% | 2412.84 | 288 / 328 | 98% | 21.33 | 175 / 178 |
| ovary | 100% | 7417.22 | 180 / 180 | 81% | 12.69 | 348 / 430 |
| liver | 50% | 1105.62 | 112 / 226 | 61% | 7.81 | 248 / 406 |
| eye | 0% | 0 | 0 / 0 | 100% | 33.95 | 80 / 80 |
| muscle | 100% | 7824.16 | 803 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 40.71 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 28.01 | 1 / 1 |
| blood vessel | 100% | 8838.66 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 4158.20 | 240 / 241 | 0% | 0 | 0 / 0 |
| adipose | 99% | 4551.98 | 1194 / 1204 | 0% | 0 | 0 / 0 |
| heart | 98% | 16516.77 | 848 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 79% | 8.40 | 23 / 29 |
| peripheral blood | 37% | 897.64 | 347 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_0015031 | Biological process | protein transport |
| GO_0045839 | Biological process | negative regulation of mitotic nuclear division |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005768 | Cellular component | endosome |
| GO_0016020 | Cellular component | membrane |
| GO_0030276 | Molecular function | clathrin binding |
| GO_0043130 | Molecular function | ubiquitin binding |
| GO_0019901 | Molecular function | protein kinase binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0035091 | Molecular function | phosphatidylinositol binding |
| Gene name | TOM1L2 |
| Protein name | Target of myb1 like 2 membrane trafficking protein Target of myb1 like 2 membrane trafficking protein (cDNA FLJ54050, highly similar to Homo sapiens target of myb1-like 2 (TOM1L2), transcript variant 2, mRNA) TOM1-like protein 2 (Target of Myb-like protein 2) |
| Synonyms | |
| Description | FUNCTION: Acts as a MYO6/Myosin VI adapter protein that targets myosin VI to endocytic structures . May also play a role in recruiting clathrin to endosomes . May regulate growth factor-induced mitogenic signaling . . |
| Accessions | ENST00000478943.5 [Q6ZVM7-4] Q6ZVM7 ENST00000379504.8 [Q6ZVM7-1] ENST00000540946.5 ENST00000535933.5 [Q6ZVM7-5] B7Z2U2 K7EKL6 F5H3S6 ENST00000318094.14 [Q6ZVM7-3] ENST00000581396.5 [Q6ZVM7-2] ENST00000542206.5 ENST00000468944.1 K7ENB0 ENST00000579586.1 ENST00000395739.8 [Q6ZVM7-3] |